What amount sold does VERDAD EUROPE FUND, L.P. report in Form D filings?

The latest linked filings report $65.5M sold across 1 identified offering(s). 1 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was VERDAD EUROPE FUND, L.P.'s most recent SEC filing?

VERDAD EUROPE FUND, L.P.'s most recent Form D filing was on 2026-01-09.

How many investors does VERDAD EUROPE FUND, L.P. have?

The most recent Form D filing lists 69 investor(s).

VERDAD EUROPE FUND, L.P.

CIK: 0001764222·Pooled Investment Fund·BOSTON, MA

Reported Sold

$65,522,826

Total Filings

Identified Offerings

Last Filed

Jan 9, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately. 1 unlinked amendment excluded.

Offering filing timeline

Jan 9, 2026Form D/A — Amendment

Reported sold: $91,833,826 · Target: N/A

No verified predecessor available.

Rule 506(b)·69 investors·Section 3(c), Section 3(c)(1)

Jan 10, 2025Form D/A — Amendment

Reported sold: $65,522,826 · Target: Indefinite

Rule 506(b)·60 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jan 12, 2024Form D/A — Amendment

Reported sold: $46,682,826 · Target: Indefinite

Rule 506(b)·47 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jan 13, 2023Form D/A — Amendment

Reported sold: $46,502,826 · Target: Indefinite

Rule 506(b)·46 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jan 14, 2022Form D/A — Amendment

Reported sold: $44,282,826 · Target: Indefinite

Rule 506(b)·44 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold

Jan 15, 2021Form D/A — Amendment

Reported sold: $32,784,011 · Target: Indefinite

Rule 506(b)·44 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jan 15, 2020Form D/A — Amendment

Reported sold: $31,167,223 · Target: Indefinite

Rule 506(b)·36 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jan 15, 2019Form D — New notice

Reported sold: $15,320,000 · Target: Indefinite

Rule 506(b)·26 investors·Section 3(c), Section 3(c)(1)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

Amendment Rate

88%

Latest reported sold across 1 identified offering

$65,522,826

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

1 unlinked amendment excluded.

Key People

VLCF GP, L.P.

Executive Officer

Appears on 8 filings

VERDAD ASSET MANAGEMENT, LLC

Executive Officer

Appears on 8 filings

DAN RASMUSSEN

Executive Officer

Appears on 8 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Jan 9, 2026	Amendment	N/A	$91,833,826	69
Jan 10, 2025	Amendment	Indefinite	$65,522,826	60
Jan 12, 2024	Amendment	Indefinite	$46,682,826	47
Jan 13, 2023	Amendment	Indefinite	$46,502,826	46
Jan 14, 2022	Amendment	Indefinite	$44,282,826	44
Jan 15, 2021	Amendment	Indefinite	$32,784,011	44
Jan 15, 2020	Amendment	Indefinite	$31,167,223	36
Jan 15, 2019	New	Indefinite	$15,320,000	26

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

AVSF - Integrated Biosciences 2026, LLC

Pooled Investment Fund

Offering target: Indefinite

Filed Nov 5, 2026